Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020

Thursday, October 6, 2016 3:45
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Big Market Research provides new report package “Global mAb Biosimilars Market- Size, Share, Trends, Forecast, Growth, Opportunities 2020”

About Biosimilars

Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product.


The global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020.

Get Sample Copy of report @

Covered in this report

The report covers the present scenario and the growth prospects of the global monoclonal antibody (mAb) biosimilars market 2016-2020. To calculate the market size, the report considers the report considers the revenue generated from the sales of mAbs. The report also considers the revenues generated from the sales of drugs that are expected to be launched during the forecast period.

The market is divided into the following segments based on geography:

• Europe

• Asia


Global Monoclonal Antibody (mAb) Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Purchase this report for the price of Single User: US $ 2500 : 


Key vendors

• Biocon

• Celltrion

• Dr. Reddy’s Laboratories

• Hospira

Other prominent vendors

• 3SBio

• Accord Healthcare

• AET Biotech

• Allergan

• Alvartis Pharma

• Amega Biotech

• Amgen

• Apotex

• Aspen

• AstraZeneca

• Aurobindo Pharma

• Baxter

• Bharat Serums

• Bio Sidus

• Biogen

• Bionovis

• Bioton

• BioXpress Therapeutics

• Boehringer Ingelheim

• Boston Oncology

• Cipla

• Coherus Biosciences

• Daiichi Sankyo

• Emcure Pharmaceuticals

• Gedeon Richter

• GeneScience Pharmaceuticals


• Hetero Drugs

• iBio

• Intas Pharmaceuticals

• JCR Pharmaceuticals

• LG Lifesciences

• Lonza

• Merck

• Mitsubishi Tanabe Pharma

• Momenta Pharmaceuticals

• Mylan

• Natco Pharma

• Novartis

• Pfenex

• Pfizer

• Ranbaxy Laboratories

• Roche Holding

• Samsung Biologics

• Sanofi

• Synthon


Market driver

•Rise in number of patent expiries

• For a full, detailed list, view our report

Market challenge

• Physicians’ reluctance to prescribe biosimilars

• For a full, detailed list, view our report

Market trend

• Emergence of biosimilars

• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Get Complete Report @

Contact us:


5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Direct: + 1-503-894-6022

Toll Free: + 1-800-910-6452

Fax: +1 (855) 550–5975







Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.